Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
interleukin 10 | 0.281 | 0.923 | 5.9E-03 |
|
disease | 0.400 | None | 1.000 | 22 | 3 | 2002 | 2019 | ||||||||
|
tryptase alpha/beta 1 | 0.722 | 0.500 | 1.3E-13 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.579 | 0.654 | 1.00 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
corticotropin releasing hormone receptor 1 | 0.517 | 0.769 | 3.8E-05 |
|
disease | 0.240 | None | 1.000 | 5 | 2 | 2010 | 2018 | ||||||||
|
corticotropin releasing hormone receptor 2 | 0.584 | 0.731 | 8.5E-17 |
|
disease | 0.230 | None | 1.000 | 4 | 2 | 2010 | 2019 | ||||||||
|
5-hydroxytryptamine receptor 7 | 0.592 | 0.500 | 4.5E-02 |
|
disease | 0.210 | None | 1.000 | 2 | 0 | 2007 | 2019 | ||||||||
|
nitric oxide synthase 3 | 0.378 | 0.885 | 6.7E-07 |
|
disease | 0.210 | None | 1.000 | 2 | 0 | 2006 | 2013 | ||||||||
|
MLX interacting protein like | 0.554 | 0.731 | 4.8E-02 |
|
disease | 0.210 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
protein disulfide isomerase family A member 3 | 0.566 | 0.769 | 1.00 |
|
disease | 0.200 | None | 1.000 | 2 | 0 | 2010 | 2015 | ||||||||
|
ribosomal protein SA | 0.485 | 0.769 | 0.93 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
inhibitor of nuclear factor kappa B kinase regulatory subunit gamma | 0.493 | 0.769 | 8.5E-02 |
|
disease | 0.200 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
disease | 0.100 | None | 0.968 | 31 | 1 | 2002 | 2019 | ||||||||
|
tumor necrosis factor | 0.231 | 0.962 | 0.80 |
|
disease | 0.100 | None | 0.900 | 30 | 1 | 2005 | 2020 | ||||||||
|
acyl-CoA dehydrogenase family member 8 | 0.506 | 0.885 | 5.6E-14 |
|
disease | 0.100 | None | 1.000 | 24 | 0 | 2007 | 2019 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
disease | 0.100 | None | 0.882 | 17 | 0 | 2012 | 2019 | ||||||||
|
interleukin 1 beta | 0.276 | 0.962 | 0.13 |
|
disease | 0.100 | None | 1.000 | 13 | 0 | 1997 | 2019 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.100 | None | 0.917 | 12 | 1 | 2010 | 2019 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 2009 | 2020 | ||||||||
|
transient receptor potential cation channel subfamily V member 1 | 0.446 | 0.885 | 1.0E-16 |
|
disease | 0.100 | None | 1.000 | 10 | 0 | 2007 | 2019 | ||||||||
|
TNF superfamily member 15 | 0.531 | 0.692 | 2.8E-03 |
|
disease | 0.100 | None | 0.800 | 10 | 2 | 2009 | 2019 | ||||||||
|
spermatogenesis associated 5 | 0.670 | 0.654 | 9.1E-20 |
|
disease | 0.100 | None | 1.000 | 1 | 1 | 2014 | 2014 | ||||||||
|
5-hydroxytryptamine receptor 3A | 0.608 | 0.538 | 1.7E-10 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2006 | 2017 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 0.070 | None | 1.000 | 7 | 1 | 2003 | 2018 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2015 | 2019 | ||||||||
|
glucagon | 0.431 | 0.885 | 3.5E-02 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 2008 | 2020 |